General Medical Use Pharmacology

GENERAL

Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic, by T. Lyttle; D. Goldstein; J. Gartz

Journal of Psychoactive Drugs Vol 28 (No. 3) July 1996, 267-290
(Abstract)

Comparison of Solution Conformational Preferences for the Hallucinogens Bufotenin and Psilocin using 360 MHz Proton NMR Spectroscopy, by G.P. Migliaccio; T.L.N. Shieh; S.R. Byrn; B.B. Hathaway; D.E. Nichols

Journal of Medicinal Chemistry Vol 24, 1981, 206-209
(No Text Available)

The Isolation of Bufotenine from Pipatdenia peregrina, by V.L. Strombert

Journal of the American Chemical Society Vol 76, Mar 20, 1954, 1707
(Abstract)

Urinary excretion of bufotenin (N,N-dimethyl-5-hydroxytryptamine) is increased in suspicious violent offenders, by J. Karkkainen; M. Raisanen; M. Huttunen; E. Kallio; H. Naukkarinen; M. Virkkunen

Psychiatry Res Vol 58, 1995, 145-152
(No Text Available)

MEDICAL USE

Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders, by N. Takeda; R. Ikeda; K. Ohba; M. Kondo

Neuroreport Vol 6 (No. 17) Nov 1995, 2378-2380
(Abstract)